Recent data reveals a paradoxical increase in abortion numbers across the United States, even as more states impose stricter abortion access laws. This surprising trend underscores the complexity of the abortion debate, as legislative actions at state levels seem to push women to seek procedures in states where access remains relatively lenient. The data highlights that despite heightened restrictions, demand for abortion services continues to rise, indicating that legal barriers may not be effectively reducing the number of abortions performed. Experts suggest these restrictions are prompting women to travel further distances, incur higher costs, and face greater logistical challenges to obtain necessary reproductive healthcare. Additionally, this surge in abortions occurs against a backdrop of increasing political tension and debate over women’s reproductive rights. Overall, the evolving landscape of abortion access in the U.S. presents significant implications for healthcare policy and women’s health advocacy.
YahooNew data shows CLYM116 reduces key IgA nephropathy biomarkers by ~70%, supporting a 12-week dosing regimen
October 24, 2026
New data released by CLIMB Bio and MabWorks reveals that their investigational drug CLYM116 significantly reduces critical biomarkers associated with IgA nephropathy by approximately 70%.